Arcutis Biotherapeutics, Inc. (ARQT) Stock Total Returns
Growth of $10,000 chart
2021-06-03 to 2026-06-03 to
$
%
%
Loading chart…
Investment Performance
Final Value
$7,984
Total Return
-20.16%
CAGR
-4.40%
Dividends
$0.00
Yield on Cost
0.00%
Rolling Returns
1-Month (21 Trading Days)
| Average | +2.51% |
| Median | -0.37% |
| Best | +191.69% |
| Worst | -59.18% |
| % of Windows Positive | 49.3% |
1-Year (252 Trading Days)
| Average | +36.32% |
| Median | +7.92% |
| Best | +586.32% |
| Worst | -89.97% |
| % of Windows Positive | 54.5% |
3-Year (756 Trading Days)
| Average | -1.59% |
| Median | -22.85% |
| Best | +154.17% |
| Worst | -73.98% |
| % of Windows Positive | 35.2% |
Risk Metrics
| Maximum Drawdown | -93.67% |
| Average Drawdown | -46.60% |
| Drawdown Duration | 1117 Trading Days |
| Sortino Ratio | 0.44 |
| Calmar Ratio | -0.05 |
| CVaR (5%) | -9.33% |
Yearly Returns
| Year | Percentage | Abs. Return | Dividends | Taxes | Trans. Costs |
|---|---|---|---|---|---|
| 2026 partial | -26.48% (-51.79% ann.) | $2648.07 | $0.00 | $0.00 | $0.00 |
| 2025 | +108.47% | +$10847.09 | $0.00 | $0.00 | $0.00 |
| 2024 | +331.27% | +$33126.99 | $0.00 | $0.00 | $0.00 |
| 2023 | -78.18% | $7817.57 | $0.00 | $0.00 | $0.00 |
| 2022 | -28.64% | $2864.03 | $0.00 | $0.00 | $0.00 |
| 2021 | -26.27% | $2627.09 | $0.00 | $0.00 | $0.00 |
| 2020 partial | +29.04% (+32.04% ann.) | +$2903.67 | $0.00 | $0.00 | $0.00 |
Market Regimes
about| Regime | Period | Percentage | Annual | Abs. Return | Dividends | Taxes | Trans. Costs |
|---|---|---|---|---|---|---|---|
| Secular stagnation / QE / low inflation / duration bull partial | January 31, 2020 – February 19, 2020 | +21.97% | +4452.73% | +$2197.25 | $0.00 | $0.00 | $0.00 |
| Pandemic shock / liquidity crash | February 20, 2020 – March 23, 2020 | +37.17% | +3588.55% | +$3717.48 | $0.00 | $0.00 | $0.00 |
| Policy bazooka / monetary euphoria | March 24, 2020 – November 6, 2020 | -50.30% | -67.53% | $5029.96 | $0.00 | $0.00 | $0.00 |
| Reopening reflation / fiscal boom / supply bottlenecks | November 9, 2020 – November 29, 2021 | -24.16% | -23.07% | $2415.78 | $0.00 | $0.00 | $0.00 |
| Inflation shock / duration crash / aggressive tightening | November 30, 2021 – November 9, 2022 | +12.37% | +13.18% | +$1237.18 | $0.00 | $0.00 | $0.00 |
| Disinflation rebound / AI-led narrow bull / higher-for-longer | November 10, 2022 – September 17, 2024 | -46.77% | -28.83% | $4676.59 | $0.00 | $0.00 | $0.00 |
| Disinflationary easing / resilient growth / AI capex under oil-shock test partial | September 18, 2024 – June 3, 2026 | +105.29% | +52.45% | +$10528.86 | $0.00 | $0.00 | $0.00 |
Dividend History
| Date | Per Share | Yield % |
|---|---|---|
| Total | 0 payments |
No dividends recorded.
All calculations use split-adjusted closing prices. Dividends are reinvested on the ex-dividend date at that day's closing price.
For each rolling window, returns are calculated at every possible starting point:
return = (value[i] ÷ value[i − windowSize] − 1) × 100
- Windows
- 1-month = 21 trading days, 1-year = 252 trading days, 3-year = 756 trading days.
- Statistics
- Average: arithmetic mean. Median: middle value when sorted. Best / Worst: max and min. % Positive: share of windows with return > 0.
The series is segmented by calendar year:
return = (endValue ÷ startValue − 1) × 100
startValue is the last value of the prior year (or the first value for the initial year). Partial first/last years are flagged. Dividends, taxes, and transaction costs are scaled proportionally to the initial investment.